Acasti Pharma (CVE:ACST) Trading Up 1.8% – Should You Buy?

Acasti Pharma Inc. (CVE:ACST)’s stock price traded up 1.8% on Thursday . The company traded as high as C$0.58 and last traded at C$0.58. 2,450 shares traded hands during mid-day trading, a decline of 63% from the average session volume of 6,576 shares. The stock had previously closed at C$0.57.

Acasti Pharma Stock Up 1.8 %

The company has a current ratio of 9.74, a quick ratio of 9.41 and a debt-to-equity ratio of 0.52. The firm has a market cap of C$25.87 million, a P/E ratio of -1.07 and a beta of 1.22. The firm’s 50 day moving average is C$0.58 and its two-hundred day moving average is C$0.58.

About Acasti Pharma

Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.